BPC-157 & TB-500 40mg (R&D Only)

£129.99

8-16 Week supply

A combined BPC-157 and TB-500 formulation (20mg each), supplied in a 40mg pre-filled research device.

Produced exclusively for controlled laboratory R&D applications. Provided in sealed batches to support compound stability analysis, delivery mechanism evaluation, and formulation studies.
Not for human or veterinary consumption.

Each BPC-157 & TB-500 40mg Pen Kit Includes:
Pre-filled Research pen (40mg total: 20mg BPC-157 + 20mg TB-500)
Research information sheet

Storage:
– Store refrigerated (2–8°C). Do not freeze.
– Supplied in fixed-volume sealed format for laboratory analysis.


Delivery: Dispatched with a cold pack
Tracked 2 DAY UK Delivery.

Research & Development purposes only. Not for human or veterinary consumption.

Category:
Description

Alluvi BPC-157 & TB-500 40mg (R&D Only)

Advanced Dual-Peptide Formula for Recovery Research and Regeneration Studies

Explore the next generation of peptide innovation with Alluvi’s BPC-157 & TB-500 (40mg) — a research-grade formulation developed for controlled laboratory evaluation of tissue repair, recovery mechanisms, and cell regeneration pathways. Designed for accuracy and purity, this compound combination supports advanced musculoskeletal and wound-healing research applications.

Product Details

  • Composition: BPC-157 (20mg) + TB-500 (20mg)

  • Total Peptide Content: 40mg per vial (R&D use only)

  • Form: Lyophilized (freeze-dried) powder

  • Purity: ≥99% (HPLC verified)

  • Packaging: Sterile-sealed glass vial in Alluvi’s research-series presentation box

Shipping and Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.